Behm BW - Search Results

1

Coil migration after transarterial coil embolization of a splenic artery pseudoaneurysm.

Tekola BD, Arner DM, Behm BW. Tekola BD, et al. Among authors: behm bw. Case Rep Gastroenterol. 2013 Nov 19;7(3):487-91. doi: 10.1159/000357151. eCollection 2013. Case Rep Gastroenterol. 2013. PMID: 24348322 Free PMC article.

2

Profile of ustekinumab and its potential in patients with moderate-to-severe Crohn's disease.

Tuskey A, Behm BW. Tuskey A, et al. Among authors: behm bw. Clin Exp Gastroenterol. 2014 May 23;7:173-9. doi: 10.2147/CEG.S39518. eCollection 2014. Clin Exp Gastroenterol. 2014. PMID: 24904220 Free PMC article. Review.

3

Antitumor Necrosis Factor-α Therapy Is Associated With Reduced Risk of Thromboembolic Events in Hospitalized Patients With Inflammatory Bowel Disease.

deFonseka AM, Tuskey A, Conaway MR, Behm BW. deFonseka AM, et al. Among authors: behm bw. J Clin Gastroenterol. 2016 Aug;50(7):578-83. doi: 10.1097/MCG.0000000000000408. J Clin Gastroenterol. 2016. PMID: 26368297

4

Dexlansoprazole MR for the management of gastroesophageal reflux disease.

Behm BW, Peura DA. Behm BW, et al. Expert Rev Gastroenterol Hepatol. 2011 Aug;5(4):439-45. doi: 10.1586/egh.11.37. Expert Rev Gastroenterol Hepatol. 2011. PMID: 21780890 Review.

5

Accelerated infliximab infusions for inflammatory bowel disease improve effectiveness.

McConnell J, Parvulescu-Codrea S, Behm B, Hill B, Dunkle E, Finke K, Snyder K, Tuskey A, Cox D, Woodward B. McConnell J, et al. World J Gastrointest Pharmacol Ther. 2012 Oct 6;3(5):74-82. doi: 10.4292/wjgpt.v3.i5.74. World J Gastrointest Pharmacol Ther. 2012. PMID: 23515325 Free PMC article.

6

Narcotic use and misuse in Crohn's disease.

Crocker JA, Yu H, Conaway M, Tuskey AG, Behm BW. Crocker JA, et al. Among authors: behm bw. Inflamm Bowel Dis. 2014 Dec;20(12):2234-8. doi: 10.1097/MIB.0000000000000194. Inflamm Bowel Dis. 2014. PMID: 25208105

7

Nonadherence to Biologic Therapies in Inflammatory Bowel Disease.

Wentworth BJ, Buerlein RCD, Tuskey AG, Overby MA, Smolkin ME, Behm BW. Wentworth BJ, et al. Among authors: behm bw. Inflamm Bowel Dis. 2018 Aug 16;24(9):2053-2061. doi: 10.1093/ibd/izy102. Inflamm Bowel Dis. 2018. PMID: 29668917

8

Opioid use and misuse in ulcerative colitis.

Chitnavis MV, Baray M, Northup PG, Tuskey AG, Behm BW. Chitnavis MV, et al. Among authors: behm bw. World J Gastrointest Pharmacol Ther. 2019 Jan 21;10(1):22-28. doi: 10.4292/wjgpt.v10.i1.22. World J Gastrointest Pharmacol Ther. 2019. PMID: 30697446 Free PMC article.

9

Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: a retrospective cohort study.

Wang J, Nakamura TI, Tuskey AG, Behm BW. Wang J, et al. Among authors: behm bw. Intest Res. 2019 Oct;17(4):496-503. doi: 10.5217/ir.2019.00050. Epub 2019 Oct 14. Intest Res. 2019. PMID: 31602961 Free PMC article.

10

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.

Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page